Push for fairer access to weight loss jabs

The government says its seeking guidance about GLP-1 treatment access and socio-economic equity issues for patients with obesity, amid the WHO’s new guidelines Federal Health Minister Mark Butler says the government has sought advice about “rolling out, in a proper way, the availability of glucagon-like peptide-1 (GLP-1) receptor agonists for obesity”. Butler said he asked